TH81391B - Iwabradine hydrochloride Bd crystal form, the process for the preparation of the substance and the pharmaceutical mixtures containing the substance - Google Patents

Iwabradine hydrochloride Bd crystal form, the process for the preparation of the substance and the pharmaceutical mixtures containing the substance

Info

Publication number
TH81391B
TH81391B TH601000840A TH0601000840A TH81391B TH 81391 B TH81391 B TH 81391B TH 601000840 A TH601000840 A TH 601000840A TH 0601000840 A TH0601000840 A TH 0601000840A TH 81391 B TH81391 B TH 81391B
Authority
TH
Thailand
Prior art keywords
substance
iwabradine
hydrochloride
preparation
crystal form
Prior art date
Application number
TH601000840A
Other languages
Thai (th)
Inventor
นางสาวแมรี่-โนแอนลล์ ออกัสเต้ นายเจอราร์ด เดเมียน นายสเตฟาเน่ ฮอร์วาธ
Original Assignee
เลส แลบบอราตัวเรส์ เซอร์วิเออร์
Filing date
Publication date
Application filed by เลส แลบบอราตัวเรส์ เซอร์วิเออร์ filed Critical เลส แลบบอราตัวเรส์ เซอร์วิเออร์
Publication of TH81391B publication Critical patent/TH81391B/en

Links

Abstract

รูปแบบผลึก เบตาd ของ อิวาบราดีน ไฮโดรคลอไรด์ ของสูตร (I) (สูตรเคมี) (I) แสดงลักษณะเฉพาะด้วยแผนผังการอ้อมของคลื่นเอ็กซ์เรย์ผงของมัน เครื่องยา The beta-crystalline form of Iwabradine hydrochloride of formula (I) (chemical formula) (I) is characterized by the indirect diagram of its powder X-ray wave.

Claims (1)

1. รูปแบบผลึก เบตาd ของ อิวาบราดีน ไฮโดรคลอไรด์ ของสูตร (I) สำหรับกระบวนการ สำหรับการเตรียมของมัน และสารผสมทางยาซึ่งมีมัน (สูตรเคมี) (I) แสดงลักษณะเฉพาะด้วยแผนผังการอ้อมของคลื่นเอ็กเรย์ผงต่อไปนี้ที่วัดการใช้ด้วย PANalytical X'Pert Pro diffractometer ร่วมกับ X'Celerator detector และแสดงในเทอมของ ตำแหน่งรังสี (Bragg's angle 2 theta, แสดงเป็นระดับขั้น) ความสูงรังสี (แสดงเป็นจ1. Beta crystal form of Iwabradine hydrochloride of formula (I) for the process. For its preparation And the containing drug mixture (chemical formula) (I) is characterized by the following diagram of the powder X-ray beam, measured for use with the PANalytical X'Pert Pro diffractometer in conjunction with an X'Celerator detector and shown. In the term of the radiation position (Bragg's angle 2 theta, expressed as a step), the radiation height (expressed as E
TH601000840A 2006-02-27 Iwabradine hydrochloride Bd crystal form, the process for the preparation of the substance and the pharmaceutical mixtures containing the substance TH81391B (en)

Publications (1)

Publication Number Publication Date
TH81391B true TH81391B (en) 2006-11-23

Family

ID=

Similar Documents

Publication Publication Date Title
HRP20080418T5 (en) CRYSTAL FORM OF BETA-D IVABRADINE HYDROCHLORIDE, PROCEDURE FOR PREPARING IT AND THE PHARMACEUTICAL MIXTURES CONTAINED BY
HRP20080406T3 (en) Crystalline form gamma of the chlorhydrate of ivabradine, process for its preparation and pharmaceutical composition containing it
HRP20080417T5 (en) Crystalline form gamma-d of the chlorohydrate of ivabradine, process for its preparation and pharmaceutical compositions containing it
Saavedra et al. The secondary amine/nitric oxide complex ion R2N [N (O) NO]-as nucleophile and leaving group in SNAr reactions
HRP20130026T1 (en) A crystalline form of posaconazole
HRP20080520T3 (en) Crystalline form beta of the chlorhydrate of ivabradine, process for its preparation and pharmaceutical composition containing it
MY139508A (en) §-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it
RU2009133262A (en) NAPADISILATE SALT OF MUSCARIN MZ-RECEPTOR ANTAGONIST
MY141306A (en) New crystalline form iv of agomelatine, a process for its preparation and pharmaceutical compositions containing it
TW200736197A (en) New crystalline form III of agomelatine, a process for its preparation and pharmaceutical compositions containing it
TH81391B (en) Iwabradine hydrochloride Bd crystal form, the process for the preparation of the substance and the pharmaceutical mixtures containing the substance
TH81393B (en) Yd crystal form of Iwabradine hydrochloride, the process for the preparation of the substance and the pharmaceutical mixtures containing the substance
TH81392B (en) Y-crystal form of Iwabradine hydrochloride, the process for the preparation of the substance and the pharmaceutical mixtures containing the substance
TH81391A (en) The crystalline form of -Bd of evaporate hydrochloride; the process for preparing the substance and pharmaceutical mixtures containing it.
TH81392A (en) The crystalline form of gamma-isolated ivabradine hydrochloride, the process for preparing it, and pharmaceutical compositions containing it.
TH81393A (en) Yd crystal form of Iwabradine hydrochloride, the process for the preparation of the substance and the pharmaceutical mixtures containing the substance
Wang et al. Unique spirocyclopiperazinium salt. Part 2: synthesis and structure–activity relationship of dispirocyclopiperazinium salts as analgesics
TH81390A (en) The crystalline form of isabradine hydrochloride-B, the process for preparing this substance, and pharmaceutical compositions containing it.
TH103575A (en) A new crystalline form VI of agomelatin Processes for preparation and pharmaceutical constituents that contain this substance.
TH87172A (en) A new type of agomelatene, a preparation process and a pharmaceutical ingredient containing this substance
TH89976B (en) Iwabradine delta crystal form. Hydrochloride, the process for the preparation of the substance and the pharmaceutical mixtures containing it
TH89977A (en) Iwabradine delta d form Hydrochloride, the process for the preparation of the substance and the pharmaceutical composition containing it
TH89977B (en) Iwabradine delta d form Hydrochloride, the process for the preparation of the substance and the pharmaceutical mixtures containing it
TH89976A (en)
TH101955B (en) Alpha crystalline form of strontium ranielate, process for the preparation of this substance and pharmaceutical mixtures containing it.